RAC 1.27% $1.55 race oncology ltd

While the non-anti cancer option was included in the analysis...

  1. 19,125 Posts.
    lightbulb Created with Sketch. 6026
    While the non-anti cancer option was included in the analysis for completeness reasons, given the difference in valuation between the two development pathways you can rationally ignore this option in any valuation. The greater risk is that something unexpected crops up in clinical development. This historical data makes this much less likely than for a totally new drug, but it still exists.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55
Change
-0.020(1.27%)
Mkt cap ! $264.0M
Open High Low Value Volume
$1.59 $1.62 $1.51 $218.3K 138.7K

Buyers (Bids)

No. Vol. Price($)
1 95 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.55 157 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.